An early alert indicator and trend forecasting model for pandemic situations in Germany.
Owkin partners with AstraZeneca to enhance gBRCA testing for breast cancer
Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a new partnership